The 24 references in paper O. Kit I., E. Frantsiyants M., E. Rostorguev E., I. Balyazin-Parfenov V., N. Cheryarina D., L. Kozlova S., Yu. Pogorelova A., О. Кит И., Е. Франциянц М., Э. Росторгуев Е., И. Балязин-Парфенов В., Н. Черярина Д., Л. Козлова С., Ю. Погорелова А. (2016) “Некоторые факторы роста в тканях новообразований головного мозга различной гистологической структуры // Some growth factors in neoplastic tissues of brain tumors of different histological structure” / spz:neicon:ogsh:y:2016:i:3:p:27-33

1
Карахан В.Б., Семенова Ж.Б., Брюховецкий А.С. и др. Проблемы диагностики и хирургии метастатических опухолей мозга. Вестник Московского онкологического общества 2004;1:3–4. [Karahan V.B., Semenova J.B., Bryukhovetsky A.S. et al. Problems of diagnosis and surgery of metastatic brain tumors. Vestnik moskovskogo onkologicheskogo obshchestva = Bulletin of Moscow Cancer Society 2004;(1):3–4. (In Russ.)].
(check this in PDF content)
2
Nassehi D. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Dan Med J 2013;60(4):B4626.
(check this in PDF content)
3
Мартынов Б.В., Гайдар Б.В., Щиголев Ю.С., Труфанов Г.Е. Метастатичес- кие опухоли головного мозга. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 476–448 (а). [Martynov B.V., Gaidar B.V., Shchigolev Yu.S., Trufanov G.E. Brain metastatic tumors. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp.
(check this in PDF content)
4
6–485. (In Russ.)]. 4. Мацко Д.Е. Патологическая анатомия важнейших хирургических заболеваний нервной системы. Практическая нейрохирургия (руководство для врачей). СПб., 2002. С. 613–635. [Matsko D.E. Pathological anatomy of the most important surgical diseases of the nervous system. Practical Neurosurgery (Guideline for Physicians). SPb., 2002. Pp. 613–635. (In Russ.)].
(check this in PDF content)
5
Gacche R.N., Meshram R.J. Targeting tumor micro-environment for design and develop ment of novel anti-angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 2013;113(2):333–54.
(check this in PDF content)
6
Nijaguna M.B., Patil V., Urbach S. et al. Glioblastoma-derived Macrophage Colonystimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding тельная связь (r = 76; р < 0,01 и r = 81; р < 0,01 соответственно). Не найдено корреляций с уровнем EGF и TGF-ß1. Известно, что EGF участвует в развитии нервной системы, и полиморфизмы гена EGF на хромосоме 4q25 группы связаны со злокачественными опухолями мозга [19]; вероятно, с этим связаны низкие показатели EGF в ткани менингиом. Известно также, что подсемейство TGF-ß, в частности, избыточно экспрессируется в некоторых видах глиобластом, которые проявляют агрессивные фенотипы [13], что тоже объясняет сниженный уровень эпидермального фактора роста в ткани менингиом. Вместе с тем имею
(check this in PDF content)
7
Gacche R.N., Meshram R.J. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta 2014;1846(1):161–79.
(check this in PDF content)
8
Welti J., Loges S., Dimmeler S., Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest 2013, Aug;123(8):3190–200.
(check this in PDF content)
9
Hashimoto I., Kodama J., Seki N. et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 2001;85:93–7.
(check this in PDF content)
10
Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1:219–27.
(check this in PDF content)
11
Nordqvist A.C., Mathiesen T. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002;57(1):19–26.
(check this in PDF content)
12
Березина В.В., Кравец Л.Я., Воловик М.Г., Шелудяков А.Ю. Реакция локального кровотока перитуморальной зоны супратенториальных опухолей на частичную декомпрессию мозга (вскрытие твердой мозговой оболочки). Физиология человека 2008;4:45–6. [Berezina V.V., Kravets L.Ya., Volovik M.G., Sheludyakov A.Yu. Reaction of local blood flow in the peritumoral area of supratentorial tumors on partial brain decompression (opening of dura mater). Fiziologiya cheloveka = Human Physiology 2008; (4): 45–6. (In Russ.)].
(check this in PDF content)
13
Nana A.W., Yang P.M., Lin H.Y. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression. Asian Pac J Cancer Prev 2015;16(16):6813–23.
(check this in PDF content)
14
Hatva E., Kaipainen A., Mentula P. et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995;146(2):368–78.
(check this in PDF content)
15
Miletic H. et al. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin 2009;13(4):455–68.
(check this in PDF content)
16
Lee S.H., Lee Y.S., Hong Y.G., Kang C.S. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. APMIS 2014;122(1):16–24.
(check this in PDF content)
17
Jensen R., Lee J. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 2012;71(1):146–56.
(check this in PDF content)
18
Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and itsreceptors. Natгure Med 2003;9(6):669–76.
(check this in PDF content)
19
Almeida L.O., Custódio A.C., Santos M.J. et al. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival. Cancer Genet Cytogenet 2010;198(1):15–21.
(check this in PDF content)
20
Bhuiyan M.I., Kim J.C., Hwang S.N. et al. Ischemic tolerance associated with VEGF-C and VEGFR-3 signaling in the hippocampus of mice. Neuroscience 2015;290:90–102.
(check this in PDF content)
21
Shin Y.J., Riew T.R., Park J.H., Lee M.Y. Expression of Vascular Endothelial Growth Factor-C (VEGF-C) and its receptor (VEGFR-3) in glial reaction caused by human mesenchymal stem cell engraftment in normal rat brain. J Histochem Cytochem 015;63(3):170–80.
(check this in PDF content)
22
Xu Y., Zhong Y.J, Zhang W.Q, Song, J.H. Cooverexpression of matrix metalloproteinases-1 and vascular endothelial growth factor-C predicts poor prognosis in patients with glioma. Epidemiol 2013;37(5):697–702.
(check this in PDF content)
23
Grau S., Thorsteinsdottir J., von Baumgarten L. et al. Bevatsizumab May cause reactivity to VEGF-C and -D in the human brain and tumor derived endothelial cells. J Neurooncol 2011;104(1): 103–12.
(check this in PDF content)
24
Shin Y.J., Choi J.S., Lee J.Y. et al. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 2008;116(5):517–27.
(check this in PDF content)